TIMP1 and ovarian carcinoma: Transcription of TIMP1 (TIMP metallopeptidase inhibitor 1) has previously been shown to be up-regulated by ITGB3 in the ovarian cancer cell line MDAH 2774 and thus may be a candidate target [19].